PPD Inc
NASDAQ:PPD
Relative Value
There is not enough data to reliably calculate the relative value of PPD.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Valuation Multiples
Multiples Across Competitors
PPD Competitors Multiples
PPD Inc Competitors
Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
---|---|---|---|---|---|---|---|---|
US |
PPD Inc
NASDAQ:PPD
|
16.6B USD | 2.8 | 45.6 | 20.3 | 29.4 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
222.7B USD | 5.2 | 37.2 | 22.9 | 33.6 | ||
US |
Danaher Corp
NYSE:DHR
|
184.5B USD | 4.2 | 22.9 | 16.6 | 20.5 | ||
CH |
Lonza Group AG
SIX:LONN
|
37.6B CHF | 5.6 | 57.5 | 19.7 | 28.9 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
40.9B USD | 2.7 | 30.1 | 16.4 | 25.4 | ||
US |
Agilent Technologies Inc
NYSE:A
|
40.8B USD | 6.1 | 33 | 26.4 | 31.7 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
54.9T KRW | 14.9 | 64 | 33.7 | 48.6 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
27.1B USD | 7.2 | 34.4 | 24 | 26.7 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.5B USD | 9.1 | 46.7 | 32.4 | 39.3 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.2B USD | 3.1 | 36.9 | 16.7 | 25.7 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
19.2B EUR | 7.1 | 75.4 | 32.4 | 53.2 |